(+)-dexrazoxane increases expression ISO RGD:733814 6480464 Dexrazoxane results in increased expression of BNIP3 mRNA CTD PMID:26873546 (+)-epicatechin-3-O-gallate multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein], BMAL1 protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein]] CTD PMID:29061316 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of BNIP3 mRNA CTD PMID:17971868 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BNIP3 mRNA] CTD PMID:31150632 (-)-alpha-phellandrene increases expression ISO RGD:1350913 6480464 alpha phellandrene results in increased expression of BNIP3 mRNA CTD PMID:25075043 (-)-demecolcine decreases expression ISO RGD:1350913 6480464 Demecolcine results in decreased expression of BNIP3 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein], BMAL1 protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein]] CTD PMID:29061316 (S)-nicotine multiple interactions ISO RGD:733814 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o more ... CTD PMID:22937105 1,2-dimethylhydrazine decreases expression ISO RGD:733814 6480464 1, 2-Dimethylhydrazine results in decreased expression of BNIP3 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:733814 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:733814 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 17alpha-ethynylestradiol affects expression ISO RGD:733814 6480464 Ethinyl Estradiol affects the expression of BNIP3 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression ISO RGD:733814 6480464 Ethinyl Estradiol results in decreased expression of BNIP3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:733814 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of BNIP3 mRNA CTD PMID:17942748 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of BNIP3 mRNA CTD PMID:32145629 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one multiple interactions ISO RGD:733814 6480464 1H-(1 more ... CTD PMID:11592958 1H-pyrazole decreases expression ISO RGD:733814 6480464 pyrazole results in decreased expression of BNIP3 mRNA CTD PMID:17945193 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733814 6480464 [decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BNIP3 mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of BNIP3 mRNA CTD PMID:15251184 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BNIP3 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733814 6480464 Tetrachlorodibenzodioxin results in decreased expression of BNIP3 mRNA CTD PMID:15251184 , PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733814 6480464 Tetrachlorodibenzodioxin results in increased expression of BNIP3 mRNA CTD PMID:21041162 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1350913 6480464 2 more ... CTD PMID:26705709 2,4-dinitrobenzenesulfonic acid decreases expression ISO RGD:733814 6480464 2, 4-dinitrobenzenesulfonic acid results in decreased expression of BNIP3 mRNA CTD PMID:30116771 2-hydroxypropanoic acid decreases expression ISO RGD:1350913 6480464 Lactic Acid results in decreased expression of BNIP3 mRNA CTD PMID:30851411 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of BNIP3 mRNA CTD PMID:21061450 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:733814 6480464 3 more ... CTD PMID:19467301 3-methyladenine decreases expression ISO RGD:1350913 6480464 3-methyladenine results in decreased expression of BNIP3 protein CTD PMID:26853465 4-hydroxynon-2-enal decreases expression ISO RGD:1350913 6480464 4-hydroxy-2-nonenal results in decreased expression of BNIP3 mRNA CTD PMID:12419474 4-phenylbutyric acid multiple interactions ISO RGD:1350913 6480464 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of BNIP3 protein] CTD PMID:33127495 5-aza-2'-deoxycytidine increases expression ISO RGD:1350913 6480464 Decitabine results in increased expression of BNIP3 mRNA, Decitabine results in increased expression of BNIP3 protein CTD PMID:15942716 more ... 5-aza-2'-deoxycytidine decreases methylation ISO RGD:1350913 6480464 Decitabine results in decreased methylation of BNIP3 promoter CTD PMID:15942716 , PMID:17195906 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1350913 6480464 [Decitabine results in decreased methylation of BNIP3 promoter] which results in increased expression of BNIP3 mRNA CTD PMID:17195906 5-aza-2'-deoxycytidine affects expression ISO RGD:1350913 6480464 Decitabine affects the expression of BNIP3 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733814 6480464 [Decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BNIP3 mRNA CTD PMID:15251184 5-aza-2'-deoxycytidine decreases expression ISO RGD:733814 6480464 Decitabine results in decreased expression of BNIP3 mRNA CTD PMID:15251184 5-azacytidine increases expression ISO RGD:1350913 6480464 Azacitidine results in increased expression of BNIP3 mRNA CTD PMID:25446377 5-fluorouracil multiple interactions ISO RGD:1350913 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of BNIP3 mRNA] CTD PMID:15016801 5-fluorouracil affects response to substance ISO RGD:1350913 6480464 BNIP3 affects the susceptibility to Fluorouracil CTD PMID:15067352 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of BNIP3 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of BNIP3 mRNA CTD PMID:19483382 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of BNIP3 mRNA CTD PMID:31881176 acrolein increases expression EXP 6480464 Acrolein results in increased expression of BNIP3 protein CTD PMID:35150775 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of BNIP3 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1350913 6480464 Acrylamide results in decreased expression of BNIP3 mRNA CTD PMID:32763439 actinomycin D multiple interactions ISO RGD:733814 6480464 [Dactinomycin co-treated with TNF protein] results in increased expression of BNIP3 mRNA more ... CTD PMID:11592958 more ... aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of BNIP3 mRNA CTD PMID:33354967 aldehydo-D-glucose multiple interactions ISO RGD:1350913 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA] CTD PMID:33962019 all-trans-retinoic acid multiple interactions ISO RGD:733814 6480464 SOX11 protein promotes the reaction [Tretinoin results in increased expression of BNIP3 mRNA] CTD PMID:17055661 all-trans-retinoic acid increases expression ISO RGD:1350913 6480464 Tretinoin results in increased expression of BNIP3 mRNA CTD PMID:33167477 alpha-phellandrene increases expression ISO RGD:1350913 6480464 alpha phellandrene results in increased expression of BNIP3 mRNA CTD PMID:25075043 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of BNIP3 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BNIP3 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1350913 6480464 pyrazolanthrone inhibits the reaction [Cadmium results in increased expression of BNIP3 protein] CTD PMID:24824807 antimycin A increases expression ISO RGD:733814 6480464 Antimycin A results in increased expression of BNIP3 mRNA CTD PMID:19304788 aristolochic acid A decreases expression ISO RGD:1350913 6480464 aristolochic acid I results in decreased expression of BNIP3 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:733814 6480464 arsenite inhibits the reaction [Dietary Fats results in decreased expression of BNIP3 mRNA] CTD PMID:30302732 arsenite(3-) multiple interactions ISO RGD:1350913 6480464 arsenite promotes the reaction [G3BP1 protein binds to BNIP3 mRNA] CTD PMID:32406909 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BNIP3 mRNA CTD PMID:19730151 arsenous acid increases response to substance ISO RGD:1350913 6480464 BNIP3 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:15592527 arsenous acid multiple interactions ISO RGD:1350913 6480464 [Arsenic Trioxide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of BNIP3 mRNA, Arsenic Trioxide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BNIP3 mRNA] CTD PMID:25446377 arsenous acid increases expression ISO RGD:1350913 6480464 Arsenic Trioxide results in increased expression of BNIP3 mRNA, Arsenic Trioxide results in increased expression of BNIP3 protein CTD PMID:15592527 , PMID:17530438 atrazine decreases expression ISO RGD:1350913 6480464 Atrazine results in decreased expression of BNIP3 mRNA CTD PMID:22378314 bafilomycin A1 multiple interactions ISO RGD:1350913 6480464 BNIP3 mutant form promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein] more ... CTD PMID:25981168 , PMID:26853465 bafilomycin A1 increases expression ISO RGD:1350913 6480464 bafilomycin A1 results in increased expression of BNIP3 mRNA, bafilomycin A1 results in increased expression of BNIP3 protein CTD PMID:25981168 , PMID:26853465 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of BNIP3 mRNA CTD PMID:19483382 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA CTD PMID:17905399 benzo[a]pyrene increases expression ISO RGD:733814 6480464 Benzo(a)pyrene results in increased expression of BNIP3 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:1350913 6480464 Benzo(a)pyrene results in increased expression of BNIP3 mRNA CTD PMID:30453624 benzo[a]pyrene affects methylation ISO RGD:1350913 6480464 Benzo(a)pyrene affects the methylation of BNIP3 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1350913 6480464 7 more ... CTD PMID:20382639 berberine multiple interactions ISO RGD:1350913 6480464 [Cisplatin co-treated with Berberine] results in increased expression of BNIP3 protein CTD PMID:36070022 berberine increases expression ISO RGD:1350913 6480464 Berberine results in increased expression of BNIP3 protein CTD PMID:36070022 bezafibrate increases expression ISO RGD:733814 6480464 Bezafibrate results in increased expression of BNIP3 mRNA CTD PMID:17118139 bicalutamide increases expression ISO RGD:1350913 6480464 bicalutamide results in increased expression of BNIP3 mRNA CTD PMID:15790403 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1350913 6480464 Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 mRNA] more ... CTD PMID:26082309 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BNIP3 mRNA CTD PMID:25181051 , PMID:33296240 bisphenol A decreases expression ISO RGD:733814 6480464 bisphenol A results in decreased expression of BNIP3 mRNA CTD PMID:33221593 bisphenol A decreases methylation ISO RGD:1350913 6480464 bisphenol A results in decreased methylation of BNIP3 promoter CTD PMID:30352284 bisphenol A affects expression ISO RGD:1350913 6480464 bisphenol A affects the expression of BNIP3 mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BNIP3 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1350913 6480464 bisphenol A results in decreased expression of BNIP3 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BNIP3 mRNA CTD PMID:30816183 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of BNIP3 gene CTD PMID:28505145 bortezomib increases expression ISO RGD:1350913 6480464 Bortezomib results in increased expression of BNIP3 protein CTD PMID:20110775 buspirone increases expression EXP 6480464 Buspirone results in increased expression of BNIP3 mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:1350913 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BNIP3 mRNA CTD PMID:29432896 cadmium atom increases expression ISO RGD:733814 6480464 Cadmium results in increased expression of BNIP3 protein CTD PMID:24824807 cadmium atom increases expression ISO RGD:1350913 6480464 Cadmium results in increased expression of BNIP3 mRNA, Cadmium results in increased expression of BNIP3 protein CTD PMID:24824807 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of BNIP3 protein CTD PMID:24824807 cadmium atom multiple interactions ISO RGD:1350913 6480464 pyrazolanthrone inhibits the reaction [Cadmium results in increased expression of BNIP3 protein], U 0126 inhibits the reaction [Cadmium results in increased expression of BNIP3 protein] CTD PMID:24824807 cadmium dichloride increases expression ISO RGD:1350913 6480464 Cadmium Chloride results in increased expression of BNIP3 mRNA, Cadmium Chloride results in increased expression of BNIP3 protein CTD PMID:12760830 more ... cadmium dichloride multiple interactions ISO RGD:1350913 6480464 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of BNIP3 protein] more ... CTD PMID:33127495 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BNIP3 protein CTD PMID:33127495 cadmium dichloride decreases expression ISO RGD:1350913 6480464 Cadmium Chloride results in decreased expression of BNIP3 mRNA CTD PMID:26472689 caffeine multiple interactions ISO RGD:733814 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 caffeine affects phosphorylation ISO RGD:1350913 6480464 Caffeine affects the phosphorylation of BNIP3 protein CTD PMID:35688186 calcidiol multiple interactions ISO RGD:733814 6480464 Calcifediol inhibits the reaction [TNF protein results in increased expression of BNIP3 protein] CTD PMID:34255241 calcidiol multiple interactions ISO RGD:1350913 6480464 Calcifediol inhibits the reaction [TNF protein promotes the reaction [BNIP3 protein binds to MAP1LC3B protein]], Calcifediol inhibits the reaction [TNF protein results in increased expression of and affects the localization of BNIP3 protein] CTD PMID:34255241 capsaicin decreases expression ISO RGD:1350913 6480464 Capsaicin results in decreased expression of BNIP3 mRNA CTD PMID:19502594 capsaicin increases expression ISO RGD:1350913 6480464 Capsaicin results in increased expression of BNIP3 mRNA CTD PMID:36044967 captan increases expression ISO RGD:733814 6480464 Captan results in increased expression of BNIP3 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1350913 6480464 Carbamazepine affects the expression of BNIP3 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:733814 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:733814 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1350913 6480464 CGP 52608 promotes the reaction [RORA protein binds to BNIP3 gene] CTD PMID:28238834 chloroacetaldehyde increases expression ISO RGD:1350913 6480464 chloroacetaldehyde results in increased expression of BNIP3 mRNA CTD PMID:25596134 chloropicrin increases expression ISO RGD:1350913 6480464 chloropicrin results in increased expression of BNIP3 mRNA CTD PMID:26352163 chloroquine multiple interactions ISO RGD:1350913 6480464 vistusertib inhibits the reaction [Chloroquine results in increased expression of BNIP3 protein] CTD PMID:26853465 chloroquine increases expression ISO RGD:1350913 6480464 Chloroquine results in increased expression of BNIP3 protein CTD PMID:26853465 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of BNIP3 mRNA CTD PMID:25596134 ciguatoxin CTX1B affects expression ISO RGD:733814 6480464 Ciguatoxins affects the expression of BNIP3 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:733814 6480464 Cisplatin results in increased expression of BNIP3 mRNA CTD PMID:21074548 cisplatin multiple interactions ISO RGD:1350913 6480464 [Cisplatin co-treated with Berberine] results in increased expression of BNIP3 protein more ... CTD PMID:29690507 more ... cisplatin decreases expression ISO RGD:1350913 6480464 Cisplatin results in decreased expression of BNIP3 mRNA CTD PMID:29690507 cisplatin affects expression ISO RGD:1350913 6480464 Cisplatin affects the expression of BNIP3 mRNA CTD PMID:23300844 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BNIP3 mRNA CTD PMID:21575413 cisplatin increases phosphorylation ISO RGD:733814 6480464 Cisplatin results in increased phosphorylation of BNIP3 protein CTD PMID:22006019 clodronic acid decreases expression ISO RGD:1350913 6480464 Clodronic Acid results in decreased expression of BNIP3 mRNA CTD PMID:25596134 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of BNIP3 mRNA CTD PMID:19483382 cobalt atom multiple interactions ISO RGD:1350913 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of BNIP3 mRNA, [tungsten carbide co-treated with Cobalt] results in increased expression of BNIP3 mRNA CTD PMID:18078969 , PMID:20105288 cobalt atom increases expression EXP 6480464 Cobalt results in increased expression of BNIP3 protein CTD PMID:24824807 cobalt atom increases expression ISO RGD:1350913 6480464 Cobalt results in increased expression of BNIP3 protein CTD PMID:24824807 cobalt dichloride multiple interactions ISO RGD:1350913 6480464 HIF1A mutant form inhibits the reaction [cobaltous chloride results in increased expression of BNIP3 mRNA] more ... CTD PMID:22269387 , PMID:25100165 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of BNIP3 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1350913 6480464 cobaltous chloride results in increased expression of BNIP3 mRNA CTD PMID:19320972 more ... cobalt dichloride increases expression ISO RGD:733814 6480464 cobaltous chloride results in increased expression of BNIP3 mRNA, cobaltous chloride results in increased expression of BNIP3 protein CTD PMID:15375294 more ... cocaine affects expression ISO RGD:733814 6480464 Cocaine affects the expression of BNIP3 mRNA CTD PMID:15681117 concanamycin A increases expression ISO RGD:1350913 6480464 concanamycin A results in increased expression of BNIP3 mRNA CTD PMID:25981168 concanamycin A multiple interactions ISO RGD:1350913 6480464 lapatinib inhibits the reaction [concanamycin A results in increased expression of BNIP3 mRNA] CTD PMID:25981168 copper atom multiple interactions ISO RGD:733814 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BNIP3 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:733814 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BNIP3 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:1350913 6480464 Copper Sulfate results in decreased expression of BNIP3 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:1350913 6480464 coumarin results in decreased phosphorylation of BNIP3 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:733814 6480464 Asbestos, Crocidolite results in decreased expression of BNIP3 mRNA CTD PMID:29279043 cycloheximide multiple interactions ISO RGD:733814 6480464 Cycloheximide inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 cyclosporin A increases expression ISO RGD:1350913 6480464 Cyclosporine results in increased expression of BNIP3 mRNA CTD PMID:25596134 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of BNIP3 mRNA CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:1350913 6480464 Cyclosporine results in decreased expression of BNIP3 mRNA CTD PMID:21632981 , PMID:25562108 cyfluthrin increases expression ISO RGD:1350913 6480464 cyfluthrin results in increased expression of BNIP3 mRNA CTD PMID:31330490 cyfluthrin multiple interactions ISO RGD:1350913 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of BNIP3 mRNA] CTD PMID:31330490 cypermethrin increases expression ISO RGD:1350913 6480464 cypermethrin results in increased expression of BNIP3 mRNA CTD PMID:32028016 D-glucose multiple interactions ISO RGD:1350913 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA] CTD PMID:33962019 deoxycholic acid affects response to substance ISO RGD:1350913 6480464 BNIP3 protein affects the susceptibility to Deoxycholic Acid CTD PMID:12507930 desferrioxamine B multiple interactions ISO RGD:1350913 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA] CTD PMID:33962019 desferrioxamine B increases expression ISO RGD:1350913 6480464 Deferoxamine results in increased expression of BNIP3 mRNA CTD PMID:33962019 dexamethasone increases expression ISO RGD:733814 6480464 Dexamethasone results in increased expression of BNIP3 mRNA CTD PMID:21041162 dexamethasone decreases expression ISO RGD:1350913 6480464 Dexamethasone results in decreased expression of BNIP3 mRNA CTD PMID:25047013 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BNIP3 mRNA CTD PMID:19730151 diarsenic trioxide increases expression ISO RGD:1350913 6480464 Arsenic Trioxide results in increased expression of BNIP3 mRNA, Arsenic Trioxide results in increased expression of BNIP3 protein CTD PMID:15592527 , PMID:17530438 diarsenic trioxide increases response to substance ISO RGD:1350913 6480464 BNIP3 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:15592527 diarsenic trioxide multiple interactions ISO RGD:1350913 6480464 [Arsenic Trioxide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of BNIP3 mRNA, Arsenic Trioxide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BNIP3 mRNA] CTD PMID:25446377 diazinon increases methylation ISO RGD:1350913 6480464 Diazinon results in increased methylation of BNIP3 gene CTD PMID:22964155 diazinon affects expression EXP 6480464 Diazinon affects the expression of BNIP3 mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression ISO RGD:733814 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:733814 6480464 Dibutyl Phthalate results in decreased expression of BNIP3 mRNA CTD PMID:21266533 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of BNIP3 mRNA CTD PMID:22546817 diethylstilbestrol increases expression ISO RGD:733814 6480464 Diethylstilbestrol results in increased expression of BNIP3 mRNA CTD PMID:21041162 dioxygen affects expression ISO RGD:733814 6480464 Oxygen deficiency affects the expression of BNIP3 mRNA CTD PMID:17193925 dioxygen multiple interactions EXP 6480464 Tea inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 protein] CTD PMID:29139225 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of BNIP3 protein CTD PMID:29139225 dioxygen increases expression ISO RGD:1350913 6480464 Oxygen deficiency results in increased expression of BNIP3 mRNA, Oxygen deficiency results in increased expression of BNIP3 protein CTD PMID:17914565 more ... dioxygen multiple interactions ISO RGD:1350913 6480464 [eprenetapopt co-treated with Oxygen deficiency] results in increased expression of BNIP3 mRNA more ... CTD PMID:26082309 , PMID:29690507 dioxygen increases expression ISO RGD:733814 6480464 Oxygen deficiency results in increased expression of BNIP3 mRNA CTD PMID:20880076 , PMID:23624791 dopamine increases expression ISO RGD:1350913 6480464 [Dopamine results in increased expression of HIF1A protein] which results in increased expression of BNIP3 mRNA, [Dopamine results in increased expression of HIF1A protein] which results in increased expression of BNIP3 protein CTD PMID:19410601 dorsomorphin multiple interactions ISO RGD:1350913 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BNIP3 mRNA CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:733814 6480464 PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BNIP3 mRNA] CTD PMID:19001878 doxorubicin increases expression ISO RGD:1350913 6480464 Doxorubicin results in increased expression of BNIP3 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:733814 6480464 Doxorubicin results in increased expression of BNIP3 mRNA CTD PMID:19001878 , PMID:25896364 doxorubicin decreases expression ISO RGD:1350913 6480464 Doxorubicin results in decreased expression of BNIP3 mRNA CTD PMID:22908232 doxycycline increases expression EXP 11561978 Doxycycline increases expression of Bnip3 mRNA in cardiac myocytes RGD endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BNIP3 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:733814 6480464 epoxiconazole results in decreased expression of BNIP3 mRNA CTD PMID:35436446 erlotinib hydrochloride multiple interactions ISO RGD:1350913 6480464 Erlotinib Hydrochloride inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 protein] CTD PMID:25981168 ethanol multiple interactions ISO RGD:733814 6480464 Dactinomycin inhibits the reaction [Ethanol results in increased expression of BNIP3 protein], FOXO3 gene mutant form inhibits the reaction [Ethanol results in increased expression of BNIP3 mRNA] CTD PMID:24095927 ethanol affects splicing ISO RGD:733814 6480464 Ethanol affects the splicing of BNIP3 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1350913 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BNIP3 mRNA CTD PMID:29432896 ethanol decreases expression ISO RGD:1350913 6480464 Ethanol results in decreased expression of BNIP3 mRNA CTD PMID:28986285 ethanol increases expression ISO RGD:733814 6480464 Ethanol results in increased expression of BNIP3 mRNA, Ethanol results in increased expression of BNIP3 protein CTD PMID:24095927 , PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1350913 6480464 Ethyl Methanesulfonate results in decreased expression of BNIP3 mRNA CTD PMID:23649840 fenamidone decreases expression ISO RGD:733814 6480464 fenamidone results in decreased expression of BNIP3 mRNA CTD PMID:27029645 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of BNIP3 mRNA CTD PMID:25596134 fluoranthene multiple interactions ISO RGD:733814 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of BNIP3 mRNA CTD PMID:28329830 flurbiprofen increases expression ISO RGD:733814 6480464 Flurbiprofen results in increased expression of BNIP3 mRNA CTD PMID:16949054 folic acid affects expression ISO RGD:1350913 6480464 Folic Acid affects the expression of BNIP3 mRNA CTD PMID:17320366 folpet increases expression ISO RGD:733814 6480464 folpet results in increased expression of BNIP3 mRNA CTD PMID:31558096 formaldehyde decreases expression ISO RGD:1350913 6480464 Formaldehyde results in decreased expression of BNIP3 mRNA CTD PMID:23649840 formaldehyde multiple interactions ISO RGD:1350913 6480464 Formaldehyde inhibits the reaction [oxalylglycine results in increased expression of BNIP3 mRNA] CTD PMID:35504338 gallic acid multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein], BMAL1 protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein]] CTD PMID:29061316 gallocatechin multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein], BMAL1 protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein]] CTD PMID:29061316 gefitinib multiple interactions ISO RGD:1350913 6480464 gefitinib inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 protein] CTD PMID:25981168 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of BNIP3 gene CTD PMID:28505145 geraniol increases expression ISO RGD:1350913 6480464 geraniol results in increased expression of BNIP3 protein CTD PMID:21371438 glucose multiple interactions ISO RGD:1350913 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA] CTD PMID:33962019 glutathione multiple interactions ISO RGD:733814 6480464 Glutathione inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 glyphosate decreases expression ISO RGD:1350913 6480464 glyphosate results in decreased expression of BNIP3 mRNA CTD PMID:31295307 hyaluronic acid multiple interactions EXP 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased expression of BNIP3 protein] CTD PMID:27082295 hyaluronic acid increases expression EXP 6480464 Hyaluronic Acid results in increased expression of BNIP3 protein CTD PMID:27082295 hydrogen peroxide affects expression ISO RGD:1350913 6480464 Hydrogen Peroxide affects the expression of BNIP3 mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein] more ... CTD PMID:29061316 , PMID:30316844 hydrogen peroxide decreases expression ISO RGD:1350913 6480464 Hydrogen Peroxide results in decreased expression of BNIP3 mRNA, Hydrogen Peroxide results in decreased expression of BNIP3 protein CTD PMID:12419474 more ... hydroquinone decreases expression ISO RGD:1350913 6480464 hydroquinone results in decreased expression of BNIP3 mRNA CTD PMID:15452088 ibuprofen increases expression EXP 6480464 Ibuprofen results in increased expression of BNIP3 mRNA CTD PMID:25596134 ifosfamide decreases expression ISO RGD:1350913 6480464 Ifosfamide results in decreased expression of BNIP3 mRNA CTD PMID:25596134 iron atom increases expression ISO RGD:733814 6480464 Iron deficiency results in increased expression of BNIP3 mRNA CTD PMID:23776592 iron(0) increases expression ISO RGD:733814 6480464 Iron deficiency results in increased expression of BNIP3 mRNA CTD PMID:23776592 isobutanol multiple interactions ISO RGD:1350913 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BNIP3 mRNA CTD PMID:29432896 isoflurane increases expression EXP 6480464 Isoflurane results in increased expression of BNIP3 mRNA CTD PMID:16978161 isoprenaline increases expression ISO RGD:733814 6480464 Isoproterenol results in increased expression of BNIP3 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:733814 6480464 Ivermectin results in decreased expression of BNIP3 mRNA CTD PMID:28942281 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of BNIP3 mRNA CTD PMID:20080153 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of BNIP3 mRNA CTD PMID:25808816 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of BNIP3 mRNA CTD PMID:19483382 lapatinib multiple interactions ISO RGD:1350913 6480464 Lapatinib inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 mRNA], Lapatinib inhibits the reaction [concanamycin A results in increased expression of BNIP3 mRNA] CTD PMID:25981168 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of BNIP3 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BNIP3 mRNA CTD PMID:16401727 , PMID:16415329 lipopolysaccharide increases expression ISO RGD:733814 6480464 Lipopolysaccharides results in increased expression of BNIP3 mRNA, Lipopolysaccharides results in increased expression of BNIP3 protein CTD PMID:21307008 lipopolysaccharide multiple interactions ISO RGD:733814 6480464 HIF1A protein promotes the reaction [Lipopolysaccharides results in increased expression of BNIP3 mRNA] more ... CTD PMID:21307008 maneb increases expression ISO RGD:1350913 6480464 Maneb results in increased expression of BNIP3 mRNA, Maneb results in increased expression of BNIP3 protein CTD PMID:18266926 manganese atom multiple interactions ISO RGD:733814 6480464 Antioxidants inhibits the reaction [Manganese results in increased expression of BNIP3 protein] CTD PMID:19442826 manganese(0) multiple interactions ISO RGD:733814 6480464 Antioxidants inhibits the reaction [Manganese results in increased expression of BNIP3 protein] CTD PMID:19442826 manganese(II) chloride multiple interactions ISO RGD:733814 6480464 [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] more ... CTD PMID:19442826 manganese(II) chloride affects response to substance ISO RGD:733814 6480464 BNIP3 protein affects the susceptibility to manganese chloride CTD PMID:19442826 melatonin multiple interactions ISO RGD:1350913 6480464 [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of BNIP3 protein]] more ... CTD PMID:31330490 more ... melatonin multiple interactions ISO RGD:733814 6480464 [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of IL1B protein]] more ... CTD PMID:37028639 melatonin increases expression ISO RGD:1350913 6480464 Melatonin results in increased expression of BNIP3 protein CTD PMID:37028639 menadione decreases expression ISO RGD:733814 6480464 Vitamin K 3 results in decreased expression of BNIP3 mRNA CTD PMID:25270620 metformin increases expression EXP 6480464 Metformin results in increased expression of BNIP3 mRNA CTD PMID:25596134 methamphetamine increases expression ISO RGD:733814 6480464 Methamphetamine results in increased expression of BNIP3 mRNA CTD PMID:36914120 methidathion decreases expression ISO RGD:733814 6480464 methidathion results in decreased expression of BNIP3 mRNA CTD PMID:34813904 methotrexate affects expression ISO RGD:733814 6480464 Methotrexate affects the expression of BNIP3 mRNA CTD PMID:18502557 methotrexate multiple interactions ISO RGD:1350913 6480464 [Methotrexate co-treated with CDKN1A protein] results in decreased expression of BNIP3 mRNA CTD PMID:18483502 methotrexate affects response to substance ISO RGD:1350913 6480464 BNIP3 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methyl methanesulfonate decreases expression ISO RGD:1350913 6480464 Methyl Methanesulfonate results in decreased expression of BNIP3 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1350913 6480464 methylmercuric chloride results in decreased expression of BNIP3 mRNA CTD PMID:23179753 , PMID:27188386 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA CTD PMID:17905399 Mitotane increases expression EXP 6480464 Mitotane analog results in increased expression of BNIP3 mRNA, Mitotane results in increased expression of BNIP3 mRNA CTD PMID:23485034 monensin A increases expression ISO RGD:1350913 6480464 Monensin results in increased expression of BNIP3 protein CTD PMID:30718715 motexafin gadolinium multiple interactions ISO RGD:1350913 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BNIP3 mRNA CTD PMID:16357179 motexafin gadolinium increases expression ISO RGD:1350913 6480464 motexafin gadolinium results in increased expression of BNIP3 mRNA CTD PMID:16357179 Myrtucommulone A affects expression ISO RGD:733814 6480464 myrtucommulone A affects the expression of BNIP3 mRNA CTD PMID:26032814 N-[3-(aminomethyl)benzyl]acetamidine multiple interactions ISO RGD:733814 6480464 [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 N-acetyl-L-cysteine multiple interactions ISO RGD:733814 6480464 Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1350913 6480464 [arsenic trioxide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of BNIP3 mRNA more ... CTD PMID:25446377 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1350913 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BNIP3 mRNA CTD PMID:25446377 N-methyl-4-phenylpyridinium decreases expression ISO RGD:733814 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BNIP3 mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of BNIP3 protein CTD PMID:17475336 more ... N-methyl-4-phenylpyridinium increases expression ISO RGD:1350913 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BNIP3 mRNA CTD PMID:18266926 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BNIP3 mRNA CTD PMID:16401727 , PMID:16415329 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of BNIP3 mRNA CTD PMID:24136188 nickel atom multiple interactions ISO RGD:733814 6480464 [nickel chloride results in increased abundance of Nickel] which results in increased expression of BNIP3 mRNA, [nickel chloride results in increased abundance of Nickel] which results in increased expression of BNIP3 protein CTD PMID:36794572 nickel dichloride multiple interactions ISO RGD:733814 6480464 [nickel chloride results in increased abundance of Nickel] which results in increased expression of BNIP3 mRNA more ... CTD PMID:12426141 more ... nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BNIP3 mRNA CTD PMID:22110744 , PMID:22546817 nickel dichloride multiple interactions ISO RGD:1350913 6480464 HIF1A protein promotes the reaction [nickel chloride results in increased expression of BNIP3 protein] CTD PMID:28552779 nickel dichloride increases expression ISO RGD:733814 6480464 nickel chloride results in increased expression of BNIP3 mRNA CTD PMID:12426141 more ... nickel dichloride increases expression ISO RGD:1350913 6480464 nickel chloride results in increased expression of BNIP3 mRNA CTD PMID:17312168 , PMID:28552779 nickel subsulfide affects expression ISO RGD:733814 6480464 nickel subsulfide affects the expression of BNIP3 mRNA CTD PMID:12729255 nickel sulfate increases expression ISO RGD:1350913 6480464 nickel sulfate results in increased expression of BNIP3 mRNA CTD PMID:17382205 nicotine multiple interactions ISO RGD:733814 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of BNIP3 mRNA CTD PMID:24136188 nitric oxide increases expression EXP 6480464 Nitric Oxide results in increased expression of BNIP3 protein CTD PMID:16002567 nitric oxide decreases expression ISO RGD:733814 6480464 Nitric Oxide results in decreased expression of BNIP3 mRNA CTD PMID:11592958 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of BNIP3 mRNA CTD PMID:33484710 nitrogen dioxide increases expression ISO RGD:1350913 6480464 Nitrogen Dioxide results in increased expression of BNIP3 mRNA CTD PMID:27206323 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of BNIP3 mRNA CTD PMID:19562491 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of BNIP3 mRNA CTD PMID:19483382 oxaliplatin decreases expression ISO RGD:1350913 6480464 oxaliplatin results in decreased expression of BNIP3 mRNA CTD PMID:17762391 p-menthan-3-ol decreases expression ISO RGD:1350913 6480464 Menthol results in decreased expression of BNIP3 mRNA CTD PMID:26760959 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of BNIP3 mRNA CTD PMID:27638505 paeoniflorin multiple interactions ISO RGD:1350913 6480464 peoniflorin inhibits the reaction [cobaltous chloride results in increased expression of BNIP3 mRNA] CTD PMID:22269387 paracetamol multiple interactions ISO RGD:1350913 6480464 [Dietary Carbohydrates co-treated with Acetaminophen] results in decreased expression of BNIP3 mRNA CTD PMID:17093179 paracetamol increases expression ISO RGD:1350913 6480464 Acetaminophen results in increased expression of BNIP3 mRNA CTD PMID:25596134 paracetamol decreases expression ISO RGD:1350913 6480464 Acetaminophen results in decreased expression of BNIP3 mRNA CTD PMID:25704631 paraquat decreases expression ISO RGD:1350913 6480464 Paraquat results in decreased expression of BNIP3 mRNA CTD PMID:18836921 paraquat multiple interactions ISO RGD:733814 6480464 [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of IL1B protein]] more ... CTD PMID:37028639 paraquat multiple interactions ISO RGD:1350913 6480464 [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Paraquat results in increased expression of COX2 protein] more ... CTD PMID:37028639 paraquat affects response to substance ISO RGD:1350913 6480464 BNIP3 protein affects the susceptibility to Paraquat CTD PMID:18056701 paraquat increases expression ISO RGD:733814 6480464 Paraquat results in increased expression of BNIP3 protein CTD PMID:18056701 , PMID:37028639 paraquat increases expression ISO RGD:1350913 6480464 Paraquat results in increased expression of BNIP3 mRNA, Paraquat results in increased expression of BNIP3 protein CTD PMID:18056701 more ... pentobarbital increases expression EXP 6480464 Pentobarbital results in increased expression of BNIP3 mRNA CTD PMID:16978161 perfluorooctanoic acid decreases expression ISO RGD:1350913 6480464 perfluorooctanoic acid results in decreased expression of BNIP3 mRNA CTD PMID:36326898 peroxynitrous acid increases expression ISO RGD:1350913 6480464 Peroxynitrous Acid results in increased expression of BNIP3 protein CTD PMID:16002567 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of BNIP3 mRNA CTD PMID:19483382 pirinixic acid increases expression ISO RGD:733814 6480464 pirinixic acid results in increased expression of BNIP3 mRNA CTD PMID:17118139 more ... pregnenolone 16alpha-carbonitrile increases expression ISO RGD:733814 6480464 Pregnenolone Carbonitrile results in increased expression of BNIP3 mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:733814 6480464 propiconazole results in decreased expression of BNIP3 mRNA CTD PMID:21278054 propofol multiple interactions ISO RGD:733814 6480464 Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 mRNA], Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 protein] CTD PMID:21307008 pyrethrins decreases expression ISO RGD:1350913 6480464 Pyrethrins results in decreased expression of BNIP3 mRNA CTD PMID:35321623 pyrethrins increases expression ISO RGD:1350913 6480464 Pyrethrins results in increased expression of BNIP3 mRNA CTD PMID:35321623 quercetin affects expression EXP 6480464 Quercetin affects the expression of BNIP3 mRNA CTD PMID:18178720 quercetin decreases expression ISO RGD:1350913 6480464 Quercetin results in decreased expression of BNIP3 mRNA CTD PMID:21632981 quercetin increases expression ISO RGD:1350913 6480464 Quercetin results in increased expression of BNIP3 mRNA CTD PMID:19729006 quinolone increases expression ISO RGD:1350913 6480464 Quinolones results in increased expression of BNIP3 mRNA CTD PMID:26082309 quinolone multiple interactions ISO RGD:1350913 6480464 [Quinolones co-treated with Oxygen deficiency] results in increased expression of BNIP3 mRNA, Quinolones inhibits the reaction [Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 protein]] CTD PMID:26082309 rac-lactic acid decreases expression ISO RGD:1350913 6480464 Lactic Acid results in decreased expression of BNIP3 mRNA CTD PMID:30851411 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BNIP3 mRNA CTD PMID:16401727 , PMID:16415329 rotenone increases expression ISO RGD:733814 6480464 Rotenone results in increased expression of BNIP3 mRNA CTD PMID:19304788 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BNIP3 mRNA CTD PMID:28374803 roxadustat multiple interactions EXP 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased expression of BNIP3 protein] CTD PMID:27082295 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1350913 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of BNIP3 mRNA CTD PMID:33725128 S-nitrosoglutathione decreases expression ISO RGD:733814 6480464 S-Nitrosoglutathione results in decreased expression of BNIP3 mRNA CTD PMID:11592958 salubrinal multiple interactions ISO RGD:1350913 6480464 salubrinal inhibits the reaction [Cadmium Chloride results in increased expression of BNIP3 protein] CTD PMID:33127495 SB 431542 multiple interactions ISO RGD:1350913 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BNIP3 mRNA CTD PMID:27188386 senecionine decreases expression ISO RGD:733814 6480464 senecionine results in decreased expression of BNIP3 protein CTD PMID:35357534 simvastatin increases expression ISO RGD:1350913 6480464 Simvastatin results in increased expression of BNIP3 mRNA CTD PMID:17428261 sirolimus multiple interactions ISO RGD:733814 6480464 Sirolimus inhibits the reaction [IL2 protein results in increased expression of BNIP3 mRNA] CTD PMID:11355896 sodium arsenite multiple interactions ISO RGD:1350913 6480464 [CARM1 mutant form co-treated with sodium arsenite] results in increased expression of BNIP3 mRNA, [PRMT1 mutant form co-treated with sodium arsenite] results in increased expression of BNIP3 mRNA CTD PMID:23699174 sodium arsenite increases expression ISO RGD:1350913 6480464 sodium arsenite results in increased expression of BNIP3 mRNA CTD PMID:20886546 , PMID:28229933 sodium arsenite decreases expression ISO RGD:1350913 6480464 sodium arsenite results in decreased expression of BNIP3 mRNA CTD PMID:12760830 sodium dichromate increases expression ISO RGD:733814 6480464 sodium bichromate results in increased expression of BNIP3 mRNA CTD PMID:31558096 sunitinib increases expression ISO RGD:1350913 6480464 Sunitinib results in increased expression of BNIP3 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:733814 6480464 Tamoxifen affects the expression of BNIP3 mRNA CTD PMID:17555576 temozolomide increases expression ISO RGD:1350913 6480464 Temozolomide results in increased expression of BNIP3 mRNA CTD PMID:31758290 teriflunomide increases expression ISO RGD:1350913 6480464 teriflunomide results in increased expression of BNIP3 mRNA CTD PMID:29427785 tert-butyl hydroperoxide decreases expression ISO RGD:1350913 6480464 tert-Butylhydroperoxide results in decreased expression of BNIP3 mRNA CTD PMID:12419474 tert-butyl hydroperoxide increases expression ISO RGD:733814 6480464 tert-Butylhydroperoxide results in increased expression of BNIP3 mRNA CTD PMID:15003993 testosterone increases expression ISO RGD:1350913 6480464 Testosterone results in increased expression of BNIP3 mRNA CTD PMID:33359661 tetrachloroethene increases expression ISO RGD:733814 6480464 Tetrachloroethylene results in increased expression of BNIP3 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:733814 6480464 Carbon Tetrachloride results in decreased expression of BNIP3 mRNA CTD PMID:17084009 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BNIP3 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BNIP3 mRNA] CTD PMID:31150632 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of BNIP3 mRNA CTD PMID:15963342 tetrachloromethane increases expression ISO RGD:733814 6480464 Carbon Tetrachloride results in increased expression of BNIP3 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:733814 6480464 CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of BNIP3 mRNA] CTD PMID:17084009 tetraethylenepentamine multiple interactions ISO RGD:1350913 6480464 tetraethylenepentamine inhibits the reaction [cobaltous chloride results in increased expression of BNIP3 mRNA] CTD PMID:25100165 thapsigargin decreases expression ISO RGD:733814 6480464 Thapsigargin results in decreased expression of BNIP3 protein CTD PMID:24648495 thapsigargin decreases expression ISO RGD:1350913 6480464 Thapsigargin results in decreased expression of BNIP3 mRNA CTD PMID:22378314 thimerosal decreases expression ISO RGD:1350913 6480464 Thimerosal results in decreased expression of BNIP3 mRNA CTD PMID:27188386 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of BNIP3 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of BNIP3 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:733814 6480464 titanium dioxide results in decreased expression of BNIP3 mRNA CTD PMID:23557971 trichloroethene multiple interactions ISO RGD:733814 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of BNIP3 protein] CTD PMID:15363585 trichloroethene increases expression ISO RGD:733814 6480464 Trichloroethylene results in increased expression of BNIP3 mRNA CTD PMID:15363585 , PMID:28973375 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA CTD PMID:17905399 trichostatin A increases expression ISO RGD:1350913 6480464 trichostatin A results in increased expression of BNIP3 mRNA CTD PMID:24935251 triptonide decreases expression ISO RGD:733814 6480464 triptonide results in decreased expression of BNIP3 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of BNIP3 mRNA CTD PMID:25596134 Tungsten carbide multiple interactions ISO RGD:1350913 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of BNIP3 mRNA, [tungsten carbide co-treated with Cobalt] results in increased expression of BNIP3 mRNA CTD PMID:18078969 , PMID:20105288 Tungsten carbide increases expression ISO RGD:1350913 6480464 tungsten carbide results in increased expression of BNIP3 mRNA CTD PMID:20105288 tunicamycin decreases expression ISO RGD:1350913 6480464 Tunicamycin results in decreased expression of BNIP3 mRNA CTD PMID:22378314 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of BNIP3 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:733814 6480464 Valproic Acid affects the expression of BNIP3 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid decreases expression ISO RGD:1350913 6480464 Valproic Acid results in decreased expression of BNIP3 mRNA CTD PMID:19949822 more ... valproic acid increases expression ISO RGD:1350913 6480464 Valproic Acid results in increased expression of BNIP3 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1350913 6480464 Valproic Acid affects the expression of BNIP3 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1350913 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:25446377 , PMID:27188386 valproic acid increases methylation ISO RGD:1350913 6480464 Valproic Acid results in increased methylation of BNIP3 gene CTD PMID:29154799 vincristine multiple interactions ISO RGD:1350913 6480464 Vincristine affects the reaction [Valproic Acid affects the localization of BNIP3 protein] CTD PMID:25446377 vincristine decreases expression ISO RGD:1350913 6480464 Vincristine results in decreased expression of BNIP3 mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1350913 6480464 vorinostat results in decreased expression of BNIP3 mRNA CTD PMID:27188386 zinc acetate multiple interactions ISO RGD:1350913 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BNIP3 mRNA CTD PMID:16357179 zinc acetate increases expression ISO RGD:1350913 6480464 Zinc Acetate results in increased expression of BNIP3 mRNA CTD PMID:16357179 zinc oxide increases expression ISO RGD:1350913 6480464 Zinc Oxide results in increased expression of BNIP3 mRNA CTD PMID:19755143 zoledronic acid decreases expression ISO RGD:1350913 6480464 zoledronic acid results in decreased expression of BNIP3 mRNA CTD PMID:19036117 zoledronic acid increases expression ISO RGD:1350913 6480464 zoledronic acid results in increased expression of BNIP3 mRNA CTD PMID:25596134
